These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 24445258)

  • 1. Neuroprotective strategies for traumatic brain injury: improving clinical translation.
    Kabadi SV; Faden AI
    Int J Mol Sci; 2014 Jan; 15(1):1216-36. PubMed ID: 24445258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies.
    Loane DJ; Faden AI
    Trends Pharmacol Sci; 2010 Dec; 31(12):596-604. PubMed ID: 21035878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotection for traumatic brain injury.
    Loane DJ; Stoica BA; Faden AI
    Handb Clin Neurol; 2015; 127():343-66. PubMed ID: 25702227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation after traumatic brain injury: opportunities for therapeutic intervention.
    Kumar A; Loane DJ
    Brain Behav Immun; 2012 Nov; 26(8):1191-201. PubMed ID: 22728326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?
    Marklund N; Hillered L
    Br J Pharmacol; 2011 Oct; 164(4):1207-29. PubMed ID: 21175576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of traumatic brain injury.
    Xiong Y; Mahmood A; Chopp M
    Nat Rev Neurosci; 2013 Feb; 14(2):128-42. PubMed ID: 23329160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigational agents for treatment of traumatic brain injury.
    Xiong Y; Zhang Y; Mahmood A; Chopp M
    Expert Opin Investig Drugs; 2015 Jun; 24(6):743-60. PubMed ID: 25727893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone neuroprotection: The background of clinical trial failure.
    Schumacher M; Denier C; Oudinet JP; Adams D; Guennoun R
    J Steroid Biochem Mol Biol; 2016 Jun; 160():53-66. PubMed ID: 26598278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targets of Neuroprotection and Review of Pharmacological Interventions in Traumatic Brain Injury.
    Hiskens MI
    J Pharmacol Exp Ther; 2022 Aug; 382(2):149-166. PubMed ID: 35644464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring new routes for neuroprotective drug development in traumatic brain injury.
    Janowitz T; Menon DK
    Sci Transl Med; 2010 Apr; 2(27):27rv1. PubMed ID: 20393189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotection in traumatic brain injury.
    Jain KK
    Drug Discov Today; 2008 Dec; 13(23-24):1082-9. PubMed ID: 18848641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection Trials in Traumatic Brain Injury.
    Chakraborty S; Skolnick B; Narayan RK
    Curr Neurol Neurosci Rep; 2016 Apr; 16(4):29. PubMed ID: 26883431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective agents in traumatic brain injury.
    Maas AI
    Expert Opin Investig Drugs; 2001 Apr; 10(4):753-67. PubMed ID: 11281824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in neuroprotection for treating traumatic brain injury.
    Cernak I
    Expert Opin Investig Drugs; 2006 Nov; 15(11):1371-81. PubMed ID: 17040197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
    Lerouet D; Marchand-Leroux C; Besson VC
    Fundam Clin Pharmacol; 2021 Jun; 35(3):524-538. PubMed ID: 33527472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the development of multifactorial therapies for the treatment of traumatic brain injury.
    Vink R; Van Den Heuvel C
    Expert Opin Investig Drugs; 2004 Oct; 13(10):1263-74. PubMed ID: 15461556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Estradiol in Traumatic Brain Injury: Mechanism and Treatment Potential.
    Kövesdi E; Szabó-Meleg E; Abrahám IM
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paths to Successful Translation of New Therapies for Severe Traumatic Brain Injury in the Golden Age of Traumatic Brain Injury Research: A Pittsburgh Vision.
    Kochanek PM; Jackson TC; Jha RM; Clark RSB; Okonkwo DO; Bayır H; Poloyac SM; Wagner AK; Empey PE; Conley YP; Bell MJ; Kline AE; Bondi CO; Simon DW; Carlson SW; Puccio AM; Horvat CM; Au AK; Elmer J; Treble-Barna A; Ikonomovic MD; Shutter LA; Taylor DL; Stern AM; Graham SH; Kagan VE; Jackson EK; Wisniewski SR; Dixon CE
    J Neurotrauma; 2020 Nov; 37(22):2353-2371. PubMed ID: 30520681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroinflammation: beneficial and detrimental effects after traumatic brain injury.
    Finnie JW
    Inflammopharmacology; 2013 Aug; 21(4):309-20. PubMed ID: 23296919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids as neuroprotective agents in traumatic brain injury.
    Biegon A
    Curr Pharm Des; 2004; 10(18):2177-83. PubMed ID: 15281893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.